A panel of biopharmaceutical leaders convened at the Galien Forum discussed the impacts of the Inflation Reduction Act so far ...

InflaRx cofounder and CEO Niels Riedemann, M.D. shares the overarching pillars that have shaped his career as a physician, ...

Growth hormone deficiency (GHD) is a rare disorder characterized by the insufficient production of growth hormone, which is essential for stimulating the growth of bones and other tissues. Children ...

Disease progression in metastatic breast cancer is a challenge that no single entity can solve alone. Breakthroughs in ...

The development of Generative AI (Gen AI) in clinical trials has been likened to a progressive journey from infancy to maturity. As Gen AI reaches advanced stages, it also introduces risks such as ...

Pivotal trial design can make or break a new therapy's commercial viability. This article explores how choosing the right ...

Anne Zimmerman, editor-in-chief of the Columbia University online journal, <a href=" target="_blank">Voices in Bioethics ...

Disagreements about budgets can delay or stall drug development. As the clinical research industry experiences unprecedented rises in costs, having the most current data available when creating and ...

Ironwood Pharmaceuticals is a smaller company than it was in 2016, when Life Science Leader wrote a feature article about its ...